Bucks – February 25, 2025 – Two thousand lives and counting were saved by the Endancular Bashir catheter, developed by the cardiologist at the Temple University, Dr. Riyaz Bashir and Bucks County Medical Device manufacturer Thrombolex. At yesterday’s press conference, Senator Steve Santarsiero (D-10), who represents the New Britain Township, in which Thrombolex is located, applauded state investments in inventive scientific research that financed the Temple device testing.
“Represent 10 with my honorth A district in which companies such as Thrombolex set up a shop, create local jobs and develop life-saving technology, “said Santarsiero. “It is easy to support state investments in innovative scientific and technological research that exerts influence on Pennsylvania, the country and the world.”
Trombolex It creates inventive and sophisticated intravascular catheters using unique pharmac and mechanical technologies to treat arterial and thrombosis (A+VTE).
“Thrombolex is just one example of what can happen when we use the rich universities network in Pennsylvania, which issue one of the most innovative research in the country.” Said the deputy secretary for technology and entrepreneurship, Jen Gilburg. “Supporting the innovative economy is of key importance for Pennsylvania’s long-term success, which is why the budget proposal of the Shapiro administration in 2025-26 includes a total of $ 50 million for a new PA innovation program, which will help us use our strengths and support our entrepreneurs.”
“This community and this region play such a leadership role in relation to science and innovation,” said Senator Vincent Hughes, chairman of the Senate Democratic means. “I want to thank the Governor Shapiro for the priority determining the priorities of this kind of innovation in his budget and Santarsiero senator for his partnership and priorites of this industry and space. Real dollars from investments bring real innovations and real life saving results. “
Dr. Riyaz Bashir has created Bashir intravascular catheters in cooperation with Trombolex in order to quickly and effectively dissolve blood clots to improve the quality of life of patients suffering from pancreatic and venous conditions (A+VTE).
Praising the involvement of Santarsiero and Hughes senators, as well as the Shapiro administration, Dr. Bashir said: “Thanks to support and involvement in the development of medical innovation, Pa continues to lead the path of transformational healthcare. Bashir catheter, developed and commercialized with Trombolex, already has a deep influence, not only in our state, but all over the country and all over the world. This technology saved thousands of lives in patients with severe blood clots. “
“I am glad that I am here,” said Irving Vaughn, a patient of Dr. Bashira, who underwent the procedure for saving life as part of research financed by the state.
Co -founder of Thrombolex, Marvin Woodall and Dr. Bashir, combined to show how the catheter effectively and effectively provides life -saving drugs to break clots in the lungs and other organs. A video from the process provided by Trombolex is available Here.
“We now had about 2,000 patients and we counted who received this treatment,” said Woodall. “Our next big step is to expand to the United States and all over the world.”
Financing of the public sector for clinical examination and emergency examination II at Temple University amounted to USD 5,950,000. The National Institutes of Health has provided USD 3,000,000 for a clinical examination, which was required to be approved by the FDA Bashir catheter for the treatment of pulmonary embolism. The Commonwealth investment in the amount of USD 2,950,000 includes USD 1,000,000 to supplement NIH financing for a clinical examination, as well USD 1,200,000 under the Reconstruction Help Program (RACP) secured by Senator Santarsiero In April 2022 and $ 750,000 DCED financing for the Rescue II process.
The Vice President of the Temple University for Research Dr. Josh Gladden emphasized cooperation and partnership, in particular financing from the Nations Community and the National Institutes of Health, which led to successful implementation of treatment. “Innovative progress, as we can see here today, not only happens. It requires commitment, investment, partnership, entrepreneurship, “said Dr. Gladden. “This requires government support and partnerships with our public sector to develop technology through clinical trials. This was supported not only by the Pennsylvania community, but also Nih, a key step in the development of any type of solution in the biomedical space. “
A full press conference can be found about Santarsiero’s Senator website.
###
